Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
Clinical trial NCT00896129 · COMPLETED
Trial details
- NCT number
- NCT00896129
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-12-01
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.